LATEST ALERTSKnowledge about cannabinoids and other cannabis compounds continues to inch forward, but though most recent major reported studies have been positive, that has not universally been the case
Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond
Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine regulation.
Cannabis companies have been pushing the envelope of acceptable marketing and business practices by insinuating unproven benefits for their products while also looking to create the strongest goods possible
As of 1st January 2025, eligible patients in Luxembourg will no longer be able to receive prescriptions for dried cannabis flower with a high THC content
Join the Tamarind Intelligence leadership team for a compelling round-table discussion with four top industry experts. They’ll reflect on the major moments of 2024 in the reduced-risk nicotine world and share their insights for 2025.
Cannabis may help sleep, according to Australian researchers who found evidence of the hypnotic properties of cannabinol (CBN) and say their study is the first to use objective measures to prove CBN increases sleep
Rupert Wilson, managing director at Strategic Business Consulting and former Rothmans International tobacco expert, sits down with Tamarind Intelligence’s Tim Phillips to examine the influence of novel nicotine products on the performance and strategic direction of public tobacco firms.
Canada-based vaping hardware maker Greentank has launched a partnership with Dubai-headquartered group AIR Global, as the shisha market specialist aims to enter the global wellness sector
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
The CBD regulatory tracker offers a deep analysis of the regulations and proposals in over 50 countries, for nine major regulatory areas: hemp cultivation, processing, flower, extracts, food, cosmetics, vaping, pet food and import/export
Brazilian pharmaceutical company Ease Labs officially announced the acquisition this month of Plena, a cannabis cultivation and extraction company based in Colombia
Just over a year after the Czech government unveiled a new, ambitious action plan to fight addictions, doubts are being raised over the government’s alignment with its own declared war on addictions
Clinical trials on CBD-based medical drug Epidiolex missed their main goal of registering a significant reduction in the frequency of seizures experienced by patients in Japan, based on the results reported by manufacturer Jazz Pharmaceuticals
Unlicensed medical cannabis prescriptions in the UK private medical sector have increased by nearly 120% between 2022 and 2023, raising concerns in the healthcare industry over prescribers’ practices
Businesses that lead product innovation with what the consumer wants will be one step ahead when it comes to taking a next-generation product to market – particularly when making PMTAs in the US
Nearly eight years after the legalisation of medical cannabis in Australia, most people who use it to treat a health condition obtain it legally, through a doctor’s prescription
The recent discovery of the illicit animal tranquilliser xylazine in cannabis vapes raises concerns about harmful contaminants. How do these substances end up in vaping products?
In this part of a series of articles celebrating the tenth anniversary of Tamarind Intelligence, we look at how the landscape of intoxicating hemp-derived cannabinoids (IHDCs) across Europe has changed over the years
An expert panel report that could set the stage for changes in coming months in the way cannabis is bought, sold and marketed across Canada is recommending wide-ranging amendments to the country’s cannabis law
Shortly after drafting its first proposal on cannabis regulation, the Czech government has banned semi-synthetic cannabinoids HHC, HHC acetate (HHC-O) and tetrahydrocannabiforol (THCP)
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
